Tetramethylpyrazine attenuates TNF-α-induced iNOS expression in human endothelial cells: Involvement of Syk-mediated activation of PI3K-IKK-IκB signaling pathways

Endothelial cells produce nitric oxide (NO) by activation of constitutive nitric oxide synthase (NOS) and transcription of inducible NO synthase (iNOS). We explored the effect of tetramethylpyrazine (TMP), a compound derived from chuanxiong, on tumor necrosis factor (TNF)-alpha-induced iNOS in human umbilical vein endothelial cells (HUVECs) and explored the signal pathways involved by using RT-PCR and Western blot. TMP suppressed TNF-alpha-induced expression of iNOS by inhibiting I kappa B kinase (IKK) phosphorylation, I kappa B degradation and nuclear factor kappa B (NF-kappa B) nuclear translocation, which were required for NO gene transcription. Exposure to wortmannin abrogated IKK/I kappa B/NF-kappa B-mediated iNOS expression, suggesting activation of such a signal pathway might be phosphoinositide-3-kinase (PI3K) dependent. Spleen tyrosine kinase (Syk) inhibitor piceatannol significantly inhibited NO production. Furthermore, piceatannol obviously suppressed TNF-alpha-induced I kappa B phosphorylation and the downstream NF-kappa B activation, suggesting that Syk is an upstream key regulator in the activation of PI3K/IKK/I kappa B-mediated signaling. TMP significantly inhibited TNF-alpha-induced phosphorylation of Syk and PI3K. Our data indicate that TMP might repress iNOS expression, at least in part, through its inhibitory effect of Syk-mediated PI3K phosphorylation in TNF-alpha-stimulated HUVECs. (C) 2013 Elsevier Inc. All rights reserved.